Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Tempest Therapeutics, Inc. (OVAS)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | | | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | | | | 0.0% | 0.0% | 267.8% | 827.1% | 811.9% |
| Gross profit | | | | 100.0% | 100.0% | -167.8% | -727.1% | -711.9% |
| Selling, general and administrative | | | | | | 9404.7% | 7538.0% | 18626.0% |
| Research and development | | | | 30.7% | 26.8% | 6215.9% | 3314.1% | 6654.5% |
| General and administrative | | | | 19.3% | 16.2% | | | |
| EBITDA | | | | 50.1% | 50.1% | -15574.2% | -11472.6% | -26091.7% |
| Depreciation | | | | 0.1% | 0.1% | 559.3% | 342.7% | 464.3% |
| EBIT | | | | 50.0% | 50.0% | -15788.5% | -11579.2% | -25992.4% |
| Pre-tax income | | | | -49.1% | -50.6% | -17256.9% | -12566.5% | -26405.8% |
| Income taxes | | | | 0.0% | 0.0% | 22.7% | 30.8% | 27.1% |
| Net income | | | | -49.1% | -50.6% | -17279.7% | -12597.2% | -26432.9% |
|